So what is going on? Three people jumping ship at the same time - some who have been around since the beginning. Is it that bad now or is it just that they are tired of drawing hung paychecks for doing nothing?
So be more forthcoming with details. What division did they leave? What city are they located? Where did they go?
Who are the three that left? I know of Chris Field but others? We heard the MSL in the Southeast left, he had been here for a while. Wonder if all went to same place.
Can you say useless? Why would they stay? They were all talented individuals but Lundbeck relegated them to useless. Managed care is something this company does not understand and they think the products are special and will sell regardless of status. Well good luck to those smart enough to get out when they can
Remember the Brintellix launch meeting. We had a one time copay card. Could not be used for refills. The logic of the brand team and managed care team was that this drug was so good that the patients would want to pay for it every month - regardless of cost. Duh!
Trin is a "me too" SSRI/SNRI wannabe. Besides some receptor binding data, there is no reason whatsoever to think that it is sufficiently superior to something like Prozac to justify a 100x higher price.
managed care managers.... don't do much, they can't tell you much. layers of bureaucrats to do your job. They have a job, most of us can't really pin down what they do other than attend managed care meetings, medicaid meetings, etc. With onfi going generic in a year there is less and less a reason to have them. In psych the market is so saturated with generics in time they can just hire lobbyist managers to do this sort of work. then we come to 120,000 dollar question northera.... its' been almost 3 years since launch and the new start result is still around 100 patients per week. If you take away the "money pits" of the country.... (where they did the trials vandy, ny, baylor, florida) you probably get 0-1 per week per territory. Is it the reps or is it the managed care environment? Do the managed care managers even know the step edits in place to get access to this medicine? Why isn't there some sort of access grid for reps to know ballpark what is required. Instead we hope when it goes in that the drug is 2nd/3rd line at a minimum and still there will be fighting to get it. onfi on the other hand....went retail and can see what happens when access is easier than this discombobulated program run by a third party program that has probably run off more patients than we have started. Did you ever think that just allowing a doctor to write and allow the patient to trial a medication and see if it works for them retail would have been a far more successful approach? Now with 4 years left to go, the generics will send a thank you card to HQ for being so incompetent. For psych we feel your pain, nothing like asking for 8th line starts where at that point a patient might have a .5% chance of responding. Nothing like science based bullshit like the old celexa story and the more "pure" ssri drug.... most docs can see through that bs today. It's all just smoke and mirrors
Impactful products sell, ineffective or marginally superior ones do not. Lundbeck had/has 3 impactful products over the past 5 years. Their names are Xenazine, Sabril, and Onfi. The rest are crap.
They thought that Celexa and Lexapro were billion dollars drugs so therefore Brintellix would also be. Times change but management's thought process didn't
That's what happens when your organization becomes inbred and you think anyone outside Valby HQ doesn't understand drug development. Hubris plain and simple, and now the company has little of value.
Excellent post! Yes, the psych world is about 98% generic. We have NO marketing dept. whatsoever. All they can come out with is a stupid patient profiles, because they have absolutely nothing else, no new data/studies etc., and never will. They will NEVER get the cog label change, and even if they do, BFD! Docs will be totally unimpressed. Soon Sabril generics will tear it apart just like Xenazine. Then Onfi next year will face generics, and all they want to do is have meetings where we accomplish nothing but wasting time and money. Why doesn't Kare know what the hell is going on over here?? Oh and guess what, we have ANOTHER fucking spreadsheet to do! I have hit the wall with Lundbeck.
based on the recently released earning statement, Onfi brings in as much as all the psych products combined. I wonder what will happen to the stock price once our revenue drops by 50%?
Hilarious, Managed care people never here this! Please tell us more about the stuff you no nothing about!
